Genetic Technologies Limited (GENE)

NASDAQ: GENE · IEX Real-Time Price · USD

2.440

-0.720 (-22.78%)

At close: Apr 18, 2024, 4:00 PM

2.470

+0.030 (1.23%)

After-hours: Apr 18, 2024, 5:27 PM EDT

Genetic Technologies Cash Flow Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2003
Net Income	-11.75	-7.13	-7.08	-6.29	-6.43	-5.46	-8.4	-8.46	-8.81	-10.13	Upgrade
Other Operating Activities	2.03	1.47	0.78	0.58	0.35	-0.17	1.55	0.73	-0.88	-0.86	Upgrade
Operating Cash Flow	-9.72	-5.66	-6.3	-5.71	-6.07	-5.64	-6.85	-7.73	-9.69	-10.99	Upgrade
Capital Expenditures	-0.02	-0.06	-0.75	-0	-0.05	-0	-0.18	-0.3	-0.14	-0.05	Upgrade
Acquisitions	-0.49	-3.4	0	0	-0.5	0	0	0	0	-0.18	Upgrade
Change in Investments	0	0	0	0.04	0	0	0	0	0	0.46	Upgrade
Other Investing Activities	0.19	0	-	0.02	0.03	0.02	0.04	-	2.1	-	Upgrade
Investing Cash Flow	-0.31	-3.46	-0.75	0.06	-0.52	0.01	-0.14	-0.3	1.97	0.23	Upgrade
Share Issuance / Repurchase	7.17	0	15.9	21.79	3.56	0	8.05	0	23.29	7	Upgrade
Debt Issued / Paid	-0.34	-0.27	-0.24	-0.13	0	0	0	0	2.15	5.58	Upgrade
Other Financing Activities	-0.92	-0.01	-1.97	-3.3	-0.43	-0.01	-0.94	-0	-2.57	-0.66	Upgrade
Financing Cash Flow	5.92	-0.28	13.69	18.36	3.13	-0.01	7.11	-0	22.87	11.92	Upgrade
Exchange Rate Effect	0.23	0.23	0.04	-0.63	0.12	0.13	-0.31	0.86	0.37	-0.06	Upgrade
Net Cash Flow	-4.12	-9.4	6.65	12.71	-3.47	-5.63	0.11	-8.02	15.14	1.17	Upgrade
Free Cash Flow	-9.74	-5.72	-7.04	-5.71	-6.12	-5.64	-7.03	-8.02	-9.83	-11.04	Upgrade
Free Cash Flow Margin	-112.14%	-84.23%	-5843.55%	-57919.69%	-24066.54%	-2979.55%	-1356.70%	-713.09%	-323.36%	-203.29%	Upgrade
Free Cash Flow Per Share	-57.65	-37.24	-49.47	-82.50	-139.41	-138.93	-198.94	-280.66	-549.61	-1152.36	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).